Literature DB >> 18558958

Transference focused psychotherapy: overview and update.

Otto F Kernberg1, Frank E Yeomans, John F Clarkin, Kenneth N Levy.   

Abstract

This paper describes a specific psychoanalytic psychotherapy for patients with severe personality disorders, its technical approach and specific research projects establishing empirical evidence supporting its efficacy. This treatment derives from the findings of the Menninger Foundation Psychotherapy Research project, and applies a model of contemporary psychoanalytic object relations theory as its theoretical foundation. The paper differentiates this treatment from alternative psychoanalytic approaches, including other types of psychoanalytic psychotherapy as well as standard psychoanalysis, and from three alternative non-analytical treatments prevalent in the treatment of borderline patients, namely, dialectic behavior therapy, supportive psychotherapy based on psychoanalytic theory, and schema focused therapy. It concludes with indications and contraindications to this particular therapeutic approach derived from the clinical experience that evolved in the course of the sequence of research projects leading to the empirical establishment of its efficacy.

Entities:  

Mesh:

Year:  2008        PMID: 18558958     DOI: 10.1111/j.1745-8315.2008.00046.x

Source DB:  PubMed          Journal:  Int J Psychoanal        ISSN: 0020-7578


  28 in total

Review 1.  Suicidal risk and management in borderline personality disorder.

Authors:  Marianne Goodman; Tracey Roiff; Allison H Oakes; Joel Paris
Journal:  Curr Psychiatry Rep       Date:  2012-02       Impact factor: 5.285

2.  Psychotherapy of Borderline Personality Disorder: Can the Supply Meet the Demand? A German Nationwide Survey in DBT Inpatient and Day Clinic Treatment Facilities.

Authors:  Christoph Richter; Bruno Steinacher; Anna zum Eschenhoff; Felix Bermpohl
Journal:  Community Ment Health J       Date:  2015-09-01

3.  Dissociation vs Repression: A New Neuropsychoanalytic Model for Psychopathology.

Authors:  Clara Mucci
Journal:  Am J Psychoanal       Date:  2021-03

Review 4.  Impulsivity and Cluster B Personality Disorders.

Authors:  Daniel Turner; Alexandra Sebastian; Oliver Tüscher
Journal:  Curr Psychiatry Rep       Date:  2017-03       Impact factor: 5.285

Review 5.  [Psychotherapy of suicidality].

Authors:  R Lindner; B Schneider
Journal:  Nervenarzt       Date:  2016-05       Impact factor: 1.214

6.  Distinct but overlapping neural networks subserve depression and insecure attachment.

Authors:  Igor I Galynker; Zimri S Yaseen; Curren Katz; Xian Zhang; Gillian Jennings-Donovan; Stephen Dashnaw; Joy Hirsch; Helen Mayberg; Lisa J Cohen; Arnold Winston
Journal:  Soc Cogn Affect Neurosci       Date:  2011-10-27       Impact factor: 3.436

Review 7.  Refining Suicide Prevention: a Narrative Review on Advances in Psychotherapeutic Tools.

Authors:  Raffaella Calati; Philippe Courtet; Jorge Lopez-Castroman
Journal:  Curr Psychiatry Rep       Date:  2018-03-08       Impact factor: 5.285

Review 8.  Cultural Aspects in Symptomatology, Assessment, and Treatment of Personality Disorders.

Authors:  Elsa F Ronningstam; Shian-Ling Keng; Maria Elena Ridolfi; Mohammad Arbabi; Brin F S Grenyer
Journal:  Curr Psychiatry Rep       Date:  2018-03-26       Impact factor: 5.285

9.  Unconscious Psychological Treatments for Physiological Survival Circuits.

Authors:  Vincent Taschereau-Dumouchel; Ka-Yuet Liu; Hakwan Lau
Journal:  Curr Opin Behav Sci       Date:  2018-05-04

10.  Frontolimbic neural circuit changes in emotional processing and inhibitory control associated with clinical improvement following transference-focused psychotherapy in borderline personality disorder.

Authors:  David L Perez; David R Vago; Hong Pan; James Root; Oliver Tuescher; Benjamin H Fuchs; Lorene Leung; Jane Epstein; Nicole M Cain; John F Clarkin; Mark F Lenzenweger; Otto F Kernberg; Kenneth N Levy; David A Silbersweig; Emily Stern
Journal:  Psychiatry Clin Neurosci       Date:  2015-10-08       Impact factor: 5.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.